CHGCF - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript
2025-07-24 14:58:44 ET
Chugai Pharmaceutical Co., Ltd. (CHGCF)
Q2 2025 Earnings Conference Call
July 24, 2025, 04:00 AM ET
Company Participants
a - Corporate Participant
Iwaaki Taniguchi - Executive VP, Head of Finance Supervisory Division, CFO & Director
Kae Miyata - Head of Corporate Communications Department
Osamu Okuda - President, CEO & Chairman
Tsukasa Kusano - Executive VP and Head of Project & Lifecycle Management Unit
Conference Call Participants
Akinori Ueda - Goldman Sachs Group, Inc., Research Division
Fumiyoshi Sakai - UBS Investment Bank, Research Division
Hidemaru Yamaguchi - Citigroup Inc., Research Division
Kazuaki Hashiguchi - Daiwa Securities Co. Ltd., Research Division
Miki Sogi - Sanford C. Bernstein & Co., LLC., Research Division
Seiji Wakao - JPMorgan Chase & Co, Research Division
Shinichiro Muraoka - Morgan Stanley, Research Division
Tony Ren - Macquarie Research
Presentation
Kae Miyata
Thank you very much for coming over to conference on financial results for the second quarter for the year ending December 2025. I will be leading today's session. I am Miyata from Corporate Communications IR Department.
So today, we have the participants at the venue as well as on the Zoom. And today's agenda is shown on the screen at the venue as well as on Page 3 of the presentation materials. And today's conference will be conducted in Japanese, but we are also providing English on Zoom webinar as a simultaneous interpretation. [Operator Instructions] We plan on spending about half an hour for Q&A session, so feel free to ask your questions. [Operator Instructions]...
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript